MEDICAMEN BIOTECH
|
MEDICAMEN BIOTECH Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹179 Cr | ₹141 Cr | ₹115 Cr | ₹11,271,608 Cr | ₹126 Cr |
| Sales | ₹179 Cr | ₹141 Cr | ₹115 Cr | ₹11,271,608 Cr | ₹126 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | - | - | - | - | - |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹179 Cr | ₹141 Cr | ₹115 Cr | ₹11,271,608 Cr | ₹126 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-12 Cr | ₹-9.71 Cr | ₹-3.34 Cr | ₹104,058 Cr | ₹-1.53 Cr |
| Raw Material Consumed | ₹85 Cr | ₹63 Cr | ₹47 Cr | ₹4,902,294 Cr | ₹67 Cr |
| Opening Raw Materials | ₹18 Cr | ₹12 Cr | ₹1.80 Cr | ₹827,581 Cr | ₹8.39 Cr |
| Purchases Raw Materials | ₹83 Cr | ₹69 Cr | ₹57 Cr | ₹4,254,636 Cr | ₹67 Cr |
| Closing Raw Materials | ₹16 Cr | ₹18 Cr | ₹12 Cr | ₹179,922 Cr | ₹8.28 Cr |
| Other Direct Purchases / Brought in cost | - | - | - | - | - |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹7.14 Cr | ₹5.67 Cr | ₹5.86 Cr | ₹268,279 Cr | ₹2.90 Cr |
| Electricity & Power | ₹7.14 Cr | ₹5.67 Cr | ₹5.86 Cr | ₹268,279 Cr | ₹2.90 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹29 Cr | ₹20 Cr | ₹15 Cr | ₹900,430 Cr | ₹9.52 Cr |
| Salaries, Wages & Bonus | ₹27 Cr | ₹18 Cr | ₹12 Cr | ₹718,805 Cr | ₹7.88 Cr |
| Contributions to EPF & Pension Funds | ₹1.55 Cr | ₹1.21 Cr | ₹0.85 Cr | ₹58,236 Cr | ₹0.60 Cr |
| Workmen and Staff Welfare Expenses | ₹0.44 Cr | ₹0.74 Cr | ₹2.02 Cr | ₹123,390 Cr | ₹1.05 Cr |
| Other Employees Cost | - | - | - | - | - |
| Other Manufacturing Expenses | ₹29 Cr | ₹27 Cr | ₹18 Cr | ₹2,647,981 Cr | ₹22 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹4.50 Cr | ₹3.97 Cr | ₹4.02 Cr | ₹337,298 Cr | ₹4.00 Cr |
| Repairs and Maintenance | ₹1.51 Cr | ₹1.36 Cr | ₹1.85 Cr | ₹162,996 Cr | ₹1.55 Cr |
| Packing Material Consumed | ₹19 Cr | ₹19 Cr | ₹8.84 Cr | ₹1,939,719 Cr | ₹13 Cr |
| Other Mfg Exp | ₹3.91 Cr | ₹2.97 Cr | ₹3.41 Cr | ₹207,968 Cr | ₹3.14 Cr |
| General and Administration Expenses | ₹8.54 Cr | ₹5.67 Cr | ₹4.93 Cr | ₹275,743 Cr | ₹3.92 Cr |
| Rent , Rates & Taxes | ₹0.54 Cr | ₹0.43 Cr | ₹0.38 Cr | ₹28,545 Cr | ₹0.39 Cr |
| Insurance | ₹0.42 Cr | ₹0.17 Cr | ₹0.12 Cr | ₹11,818 Cr | ₹0.14 Cr |
| Printing and stationery | ₹1.88 Cr | ₹0.80 Cr | ₹0.47 Cr | ₹34,396 Cr | ₹0.41 Cr |
| Professional and legal fees | ₹1.56 Cr | ₹0.85 Cr | ₹1.98 Cr | ₹90,743 Cr | ₹1.34 Cr |
| Traveling and conveyance | ₹1.14 Cr | ₹0.73 Cr | ₹0.38 Cr | ₹14,423 Cr | ₹0.33 Cr |
| Other Administration | ₹3.00 Cr | ₹2.68 Cr | ₹1.60 Cr | ₹95,817 Cr | ₹1.31 Cr |
| Selling and Distribution Expenses | ₹7.27 Cr | ₹3.48 Cr | ₹3.36 Cr | ₹171,268 Cr | ₹1.77 Cr |
| Advertisement & Sales Promotion | ₹2.75 Cr | ₹0.72 Cr | ₹0.46 Cr | ₹5,656 Cr | ₹0.17 Cr |
| Sales Commissions & Incentives | ₹1.81 Cr | ₹0.89 Cr | ₹0.79 Cr | ₹37,206 Cr | - |
| Freight and Forwarding | ₹2.66 Cr | ₹1.77 Cr | ₹2.08 Cr | ₹109,869 Cr | ₹1.21 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹0.05 Cr | ₹0.10 Cr | ₹0.03 Cr | ₹18,537 Cr | ₹0.39 Cr |
| Miscellaneous Expenses | ₹1.27 Cr | ₹1.18 Cr | ₹1.08 Cr | ₹34,435 Cr | ₹0.32 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | - | ₹0.01 Cr | ₹0.00 Cr | ₹142 Cr | ₹0.06 Cr |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹1.27 Cr | ₹1.17 Cr | ₹1.07 Cr | ₹34,293 Cr | ₹0.26 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹156 Cr | ₹117 Cr | ₹91 Cr | ₹9,304,488 Cr | ₹106 Cr |
| Operating Profit (Excl OI) | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹1,967,120 Cr | ₹19 Cr |
| Other Income | ₹2.33 Cr | ₹2.46 Cr | ₹1.72 Cr | ₹75,405 Cr | ₹1.94 Cr |
| Interest Received | ₹0.72 Cr | ₹0.72 Cr | ₹0.14 Cr | ₹15,331 Cr | ₹0.32 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - | - |
| Profits on sale of Investments | - | - | ₹0.00 Cr | ₹417 Cr | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹1.39 Cr | ₹1.48 Cr | ₹1.45 Cr | ₹47,094 Cr | ₹1.37 Cr |
| Others | ₹0.22 Cr | ₹0.27 Cr | ₹0.13 Cr | ₹12,563 Cr | ₹0.25 Cr |
| Operating Profit | ₹26 Cr | ₹27 Cr | ₹26 Cr | ₹2,042,525 Cr | ₹21 Cr |
| Interest | ₹5.67 Cr | ₹3.39 Cr | ₹1.94 Cr | ₹151,152 Cr | ₹0.93 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹1.28 Cr | ₹0.47 Cr | ₹0.54 Cr | ₹44,751 Cr | ₹0.36 Cr |
| Other Interest | ₹4.40 Cr | ₹2.92 Cr | ₹1.40 Cr | ₹106,401 Cr | ₹0.57 Cr |
| PBDT | ₹20 Cr | ₹23 Cr | ₹24 Cr | ₹1,891,373 Cr | ₹20 Cr |
| Depreciation | ₹7.09 Cr | ₹6.37 Cr | ₹5.77 Cr | ₹251,971 Cr | ₹2.50 Cr |
| Profit Before Taxation & Exceptional Items | ₹13 Cr | ₹17 Cr | ₹18 Cr | ₹1,639,401 Cr | ₹18 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹13 Cr | ₹17 Cr | ₹18 Cr | ₹1,639,401 Cr | ₹18 Cr |
| Provision for Tax | ₹3.58 Cr | ₹2.32 Cr | ₹3.20 Cr | ₹426,457 Cr | ₹4.69 Cr |
| Current Income Tax | ₹4.22 Cr | ₹3.70 Cr | ₹3.98 Cr | ₹414,515 Cr | ₹4.94 Cr |
| Deferred Tax | ₹-0.64 Cr | ₹-1.38 Cr | ₹-0.78 Cr | ₹11,943 Cr | ₹-0.25 Cr |
| Other taxes | - | - | - | - | - |
| Profit After Tax | ₹9.49 Cr | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹9.49 Cr | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹83 Cr | ₹69 Cr | ₹55 Cr | ₹4,358,841 Cr | ₹32 Cr |
| Appropriations | ₹92 Cr | ₹84 Cr | ₹70 Cr | ₹5,571,785 Cr | ₹45 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹1.27 Cr | ₹1.18 Cr | ₹1.22 Cr | ₹61,083 Cr | ₹1.47 Cr |
| Equity Dividend % | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹5.00 |
| Earnings Per Share | ₹7.47 | ₹11.64 | ₹12.19 | ₹9.93 | ₹10.88 |
| Adjusted EPS | ₹7.47 | ₹11.64 | ₹12.19 | ₹9.93 | ₹10.88 |
Compare Income Statement of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹484.3 Cr | 12.2% | 6.6% | -28.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 12.2% |
6.6% |
-28.9% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses